flynn	10.1200/JCO.2017.74.1165	<http://dx.doi.org/10.1200/jco.2017.74.1165>; rel="canonical", <http://ascopubs.org/doi/pdf/10.1200/JCO.2017.74.1165>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2017.74.1165"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jonathan-polikoff-vjxl5htfgrz0"><j.3:name>Jonathan Polikoff</j.3:name><j.3:familyName>Polikoff</j.3:familyName><j.3:givenName>Jonathan</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/david-d-biggs-vjxl5htfgrz0"><j.3:name>David D. Biggs</j.3:name><j.3:familyName>Biggs</j.3:familyName><j.3:givenName>David D.</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="info:doi/10.1200/jco.2017.74.1165"/><j.2:volume>35</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/thomas-e-seay-vjxl5htfgrz0"><j.3:name>Thomas E. Seay</j.3:name><j.3:familyName>Seay</j.3:familyName><j.3:givenName>Thomas E.</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>35</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jong-hyeon-jeong-vjxl5htfgrz0"><j.3:name>Jong-Hyeon Jeong</j.3:name><j.3:familyName>Jeong</j.3:familyName><j.3:givenName>Jong-Hyeon</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/sandra-m-swain-vjxl5htfgrz0"><j.3:name>Sandra M. Swain</j.3:name><j.3:familyName>Swain</j.3:familyName><j.3:givenName>Sandra M.</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.1:startingPage>3942</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/reena-s-cecchini-vjxl5htfgrz0"><j.3:name>Reena S. Cecchini</j.3:name><j.3:familyName>Cecchini</j.3:familyName><j.3:givenName>Reena S.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>3942</j.2:pageStart><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2017.74.1165"/><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/tanya-a-wahl-vjxl5htfgrz0"><j.3:name>Tanya A. Wahl</j.3:name><j.3:familyName>Wahl</j.3:familyName><j.3:givenName>Tanya A.</j.3:givenName></j.3:Person></j.0:creator><j.1:endingPage>3948</j.1:endingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/eleftherios-p-mamounas-vjxl5htfgrz0"><j.3:name>Eleftherios P. Mamounas</j.3:name><j.3:familyName>Mamounas</j.3:familyName><j.3:givenName>Eleftherios P.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/adam-m-brufsky-vjxl5htfgrz0"><j.3:name>Adam M. Brufsky</j.3:name><j.3:familyName>Brufsky</j.3:familyName><j.3:givenName>Adam M.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/louis-fehrenbacher-vjxl5htfgrz0"><j.3:name>Louis Fehrenbacher</j.3:name><j.3:familyName>Fehrenbacher</j.3:familyName><j.3:givenName>Louis</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/priya-rastogi-vjxl5htfgrz0"><j.3:name>Priya Rastogi</j.3:name><j.3:familyName>Rastogi</j.3:familyName><j.3:givenName>Priya</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/james-n-atkins-vjxl5htfgrz0"><j.3:name>James N. Atkins</j.3:name><j.3:familyName>Atkins</j.3:familyName><j.3:givenName>James N.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/patricia-a-ganz-vjxl5htfgrz0"><j.3:name>Patricia A. Ganz</j.3:name><j.3:familyName>Ganz</j.3:familyName><j.3:givenName>Patricia A.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>3948</j.2:pageEnd><owl:sameAs rdf:resource="doi:10.1200/jco.2017.74.1165"/><j.0:identifier>10.1200/jco.2017.74.1165</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/charles-e-geyer-vjxl5htfgrz0"><j.3:name>Charles E. Geyer</j.3:name><j.3:familyName>Geyer</j.3:familyName><j.3:givenName>Charles E.</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2017-12-10</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/patrick-j-flynn-vjxl5htfgrz0"><j.3:name>Patrick J. Flynn</j.3:name><j.3:familyName>Flynn</j.3:familyName><j.3:givenName>Patrick J.</j.3:givenName></j.3:Person></j.0:creator><j.1:doi>10.1200/jco.2017.74.1165</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/james-l-wade-vjxl5htfgrz0"><j.3:name>James L. Wade</j.3:name><j.3:familyName>Wade</j.3:familyName><j.3:givenName>James L.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/norman-wolmark-vjxl5htfgrz0"><j.3:name>Norman Wolmark</j.3:name><j.3:familyName>Wolmark</j.3:familyName><j.3:givenName>Norman</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/john-l-zapas-vjxl5htfgrz0"><j.3:name>John L. Zapas</j.3:name><j.3:familyName>Zapas</j.3:familyName><j.3:givenName>John L.</j.3:givenName></j.3:Person></j.0:creator><j.0:title>Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2</j.0:title><j.2:doi>10.1200/jco.2017.74.1165</j.2:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/howard-m-gross-vjxl5htfgrz0"><j.3:name>Howard M. Gross</j.3:name><j.3:familyName>Gross</j.3:familyName><j.3:givenName>Howard M.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/edward-h-romond-vjxl5htfgrz0"><j.3:name>Edward H. Romond</j.3:name><j.3:familyName>Romond</j.3:familyName><j.3:givenName>Edward H.</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
